Biostar Pharmaceuticals has recently applied for a Nasdaq listing and could be a double or triple once it trades on the Nasdaq.
If you happened to have perfect timing during the worst financial crisis since the great depression and bought shares of Bristol Meyers you would now be up by 50%, and that is with the stock currently trading near a 52-week high. That is the absolute best you could do. Shares of Lilly, Pfizer and Merck delivered near identical returns.
Had you simply bought the Dow, you would be up by more than that 60%, and in fact if you had simply thrown darts at a board to pick your stocks you would likely have made a greater return. The fact of the matter is that big cap pharma is safe and boring and doesn't go up or down. It is nearly impossible to earn a significant return. As a result, I avoid putting money into big-cap pharma because it is too stable. For the opposite reason, I avoid putting money into biotech stocks. Money losing biotech stocks more resemble a trip to the casino than they do an investment decision....
Click to view a price quote on BSPM.
Click to research the Drugs industry.